Business Model

Edinburgh Pharmaceuticals in developing new formulations, undertaking bioequivalence studies, clinical trials, obtaining Drug Controller General of India’s (DCGI) approval for franchise and marketing of new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Edinburgh’s own technology to its customers under their brand names. Edinburgh Pharmaceuticals franschise innovative and technology driven products